Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Gynecologic Oncology|November 3, 2015
Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumorsMatthew F Buas, Haiwei Gu, Danijel Djukovic, et al.
JCO Precision Oncology|May 18, 2026
Impact of Multicancer Screening on Late-Stage Cancer at Diagnosis in Breast Cancer Survivors: A Modeling StudyKemal C Gogebakan, Jane Lange, Roman Gulati, et al.
Gynecologic Oncology|March 1, 1992
Continuous infusion of low-dose 5-fluorouracil and radiation therapy for poor-prognosis squamous cell carcinoma of the uterine cervixC W Drescher, G C Reid, K Terada, et al.
Gynecologic Oncology|December 1, 2009
Use of a Symptom Index, CA125, and HE4 to predict ovarian cancerM Robyn Andersen, Barbara A Goff, Kimberly A Lowe, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 14, 2020
Biomarkers and Strategies for Early Detection of Ovarian CancerRobert C Bast, Zhen Lu, Chae Young Han, et al.
Gynecologic Oncology|March 22, 2003
Adequate staging for uterine cancer can be performed through Pfannenstiel incisionsNeil S Horowitz, Matthew A Powell, Charles W Drescher, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|November 16, 2018
False-positive screening events and worry influence decisions about surgery among high-risk womenM Robyn Andersen, Beth Y Karlan, Charles W Drescher, et al.
Molecular & Cellular Proteomics : MCP|December 2, 2005
Proteins associated with Cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levelsJennifer J Stewart, James T White, Xiaowei Yan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2012
Longitudinal screening algorithm that incorporates change over time in CA125 levels identifies ovarian cancer earlier than a single-threshold ruleCharles W Drescher, Chirag Shah, Jason Thorpe, et al.
Gynecologic Oncology|February 15, 2003
Three-consecutive-day topotecan is an active regimen for recurrent epithelial ovarian cancerJohn V Brown, William A Peters, Mark A Rettenmaier, et al.
Pageof 10